Australia markets closed

Universe Pharmaceuticals INC (UPC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.6401+0.0327 (+5.38%)
At close: 04:00PM EDT
0.6748 +0.03 (+5.42%)
Pre-market: 04:50AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.29M
Enterprise value -11.88M
Trailing P/E 2.35
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.26
Price/book (mrq)0.20
Enterprise value/revenue -0.25
Enterprise value/EBITDA -1.47

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-73.88%
S&P500 52-week change 3-14.73%
52-week high 32.5000
52-week low 30.5000
50-day moving average 30.5971
200-day moving average 31.0362

Share statistics

Avg vol (3-month) 336.36k
Avg vol (10-day) 319.91k
Shares outstanding 521.75M
Implied shares outstanding 6N/A
Float 87.08M
% held by insiders 157.38%
% held by institutions 11.37%
Shares short (14 Sept 2022) 48.01k
Short ratio (14 Sept 2022) 40.16
Short % of float (14 Sept 2022) 40.09%
Short % of shares outstanding (14 Sept 2022) 40.04%
Shares short (prior month 14 Aug 2022) 421.9k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 12.33%
Operating margin (ttm)14.01%

Management effectiveness

Return on assets (ttm)6.05%
Return on equity (ttm)10.56%

Income statement

Revenue (ttm)47.89M
Revenue per share (ttm)2.20
Quarterly revenue growth (yoy)-0.40%
Gross profit (ttm)25.33M
Net income avi to common (ttm)5.9M
Diluted EPS (ttm)0.2600
Quarterly earnings growth (yoy)-75.80%

Balance sheet

Total cash (mrq)28.58M
Total cash per share (mrq)1.31
Total debt (mrq)4.41M
Total debt/equity (mrq)7.21
Current ratio (mrq)5.06
Book value per share (mrq)2.81

Cash flow statement

Operating cash flow (ttm)3M
Levered free cash flow (ttm)-14.28M